Education
About Us
Working with TipRanks
Follow Us
Csl Ltd (CSLLY)
:CSLLY
CSLLY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$70.06 - $104.87
Previous CloseN/A
Volume10.38K
Average Volume (3M)2.33K
Market Cap
$78.86B
Enterprise Value$88.20B
Total Cash (Recent Filing)$1.52B
Total Debt (Recent Filing)$11.96B
Price to Earnings (P/E)28.8
Beta0.45
Next Earnings
Aug 18, 2025EPS EstimateN/A
Last Dividend Ex-Date
Mar 11, 2025Dividend Yield1.47%
Share Statistics
EPS (TTM)2.07
Shares Outstanding968,424,260
10 Day Avg. Volume2,476
30 Day Avg. Volume2,335
Financial Highlights & Ratios
PEG Ratio46.13
Price to Book (P/B)4.26
Price to Sales (P/S)0.00
P/FCF Ratio42.14
Enterprise Value/Market Cap1.12
Enterprise Value/Revenue1.53
Enterprise Value/Gross Profit11.99
Enterprise Value/Ebitda4.78
Forecast
1Y Price Target
$86.00Price Target Upside6.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
CSL News
PremiumCompany Announcements
CSL Limited Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
CSL Limited Reports Strong Half-Year Financial Performance
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01% Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
CSLLY FAQ
What was Csl Ltd’s price range in the past 12 months?
Csl Ltd lowest stock price was $70.06 and its highest was $104.87 in the past 12 months.
What is Csl Ltd’s market cap?
Csl Ltd’s market cap is $78.86B.
When is Csl Ltd’s upcoming earnings report date?
Csl Ltd’s upcoming earnings report date is Aug 18, 2025 which is in 30 days.
How were Csl Ltd’s earnings last quarter?
Csl Ltd released its earnings results on Feb 11, 2025. The company reported $2.074 earnings per share for the quarter, beating the consensus estimate of N/A by $2.074.
Is Csl Ltd overvalued?
According to Wall Street analysts Csl Ltd’s price is currently Undervalued.
Does Csl Ltd pay dividends?
Csl Ltd pays a Semiannually dividend of $0.6 which represents an annual dividend yield of 1.47%. See more information on Csl Ltd dividends here
What is Csl Ltd’s EPS estimate?
Csl Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Csl Ltd have?
Csl Ltd has 968,424,260 shares outstanding.
What happened to Csl Ltd’s price movement after its last earnings report?
Csl Ltd reported an EPS of $2.074 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.486%.
Which hedge fund is a major shareholder of Csl Ltd?
Currently, no hedge funds are holding shares in CSLLY
CSL Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$86.00 (6.79% Upside)
$86.00 (6.79% Upside)
Hedge Fund Trend
Decreased
By 33.1K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-21.07%
12-Months-Change
Fundamentals
Return on Equity
15.36%
Trailing 12-Months
Asset Growth
3.06%
Trailing 12-Months
Company Description
Csl Ltd
CSL Limited (CSLLY) is a global biotechnology company that specializes in the development and manufacture of innovative biotherapies and influenza vaccines. It operates through two main segments: CSL Behring and Seqirus. CSL Behring focuses on providing life-saving treatments for people with rare and serious diseases through its plasma-derived therapies, recombinant therapies, and related products. Seqirus, on the other hand, is one of the largest influenza vaccine companies in the world, supplying vaccines to both public and private sectors globally.